Latest News

Dow Jones Newswires: Stryker’s Q4 EPS misses Wall Street target

0

Stryker Corp. reported higher fourth-quarter profit and sales on Thursday, but per-share earnings missed Wall Street’s target.

Profit for the medical technology products and services company SYK rose to $662 million from $568 million a year earlier. On a per-share basis, profit was $1.73, or $2.71 as adjusted. Analysts surveyed by FactSet expected $2.48 a share, or $2.72 a share as adjusted.

The results included $137 million in asset impairments, primarily in-process research and development along with plant and equipment as a result of pandemic-related demand impacts on in-process product development and other divestiture and restructuring activities, the company said.

Net sales for the quarter rose to $4.7 billion from $4.26 billion a year earlier. Analysts expected $4.65 billion in revenue.

The company ended the year with a $2 billion profit on $17.11 billion in sales, compared with a profit of $1.6 billion and $14.35 billion in sales a year earlier.

Chief Executive Kevin Lobo had said that the resurgence of Covid-19 cases had largely affected Stryker’s U.S. implant-related businesses with scheduled procedures being deferred. On Thursday, Lobo said the company delivered a strong year of financial results, despite the challenges of the pandemic.

Write to Maria Armental at maria.armental@wsj.com

Earnings Results: Robinhood stock tanks as trading app posts wider Q4 loss, weaker outlook

Previous article

Home Depot names company veteran Ted Decker as CEO

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News